Medisix Therapeutics focuses on developing chimeric antigen receptor T cells for the treatment of lymphoma and leukemia.
Business Model:
Revenue: $1.1M
Employees: 1-10
Address: -
City: Singapore
State: other
Zip: 238801
Country: SG
Medisix Therapeutics focuses on developing chimeric antigen receptor T cells for the treatment of lymphoma and leukemia.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2018 | Series A | 3 | $20M |
Lightstone Ventures OUP (Osage University Partners) Temasek Holdings Lightstone Ventures OUP (Osage University Partners) Temasek Holdings |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|